Skip to main content
logo
Dermapharm Holding SE (FRA:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
33.20
-0.30 (-0.90%)
At close: Aug 1, 2025, 10:00 PM CET

Intercept Pharmaceuticals Revenue

Dermapharm Holding SE had revenue of 305.26M EUR in the quarter ending March 31, 2025, with 1.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.20% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.

Revenue (ttm)
1.20B
Revenue Growth
+6.20%
P/S Ratio
1.49
Revenue / Employee
332.22K
Employees
3,610
Market Cap
1.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.20B44.72M3.89%
Dec 31, 20231.15B110.19M10.59%
Dec 31, 20221.04B80.46M8.38%
Dec 31, 2021960.09M151.78M18.78%
Dec 31, 2020808.31M93.94M13.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SAP SE35.89B
Siemens Aktiengesellschaft77.82B
Deutsche Telekom AG120.25B
Allianz SE109.03B
Rheinmetall AG10.48B
Siemens Energy AG37.44B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München61.84B
Deutsche Bank Aktiengesellschaft30.07B
Revenue Rankings

Dermapharm Holding SE News

More News